Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-004747
Filing Date
2020-02-14
Accepted
2020-02-14 19:16:47
Documents
2
Period of Report
2020-02-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5309
2 EX-24 DOCUMENT attachment1.htm EX-24 4411
  Complete submission text file 0000899243-20-004747.txt   11134
Mailing Address 2755 CAMPUS DRIVE, SUITE 240 SAN MATEO CA 94403-2538
Business Address
MOMTAZEE JAMES C (Reporting) CIK: 0001209181 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38959 | Film No.: 20622772

Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations